However, we also indicated and implied that HIF-1α and HIF-2α are diverse by nature, and proposed an alternative perspective to elucidate the role of HIF-α dynamics in tumor progression; that cancer optimizes the HIF pathway for tumor progression through balancing of the α-subunit. The gene discussed is EPAS1; the disease is cancer.